Melatonin: Quantitative analysis in pharmaceutical oral dosage forms using thin-layer chromatography (TLC) densitometry

Farmaco

Volumn 53, Issue 6, 1998, Pages 443-447

  Costantini, Alberto ^a   Paoli, Flavio ^a  

^a Stabilimento Chimico Farmaceutico M   (Italy)

Author keywords

Densitometry; Melatonin; Oral dosage forms; Thin layer chromatography

Indexed keywords

MELATONIN; NON PRESCRIPTION DRUG;

ARTICLE; DENSITOMETRY; DRUG DETERMINATION; DRUG DOSAGE FORM; HIGH PERFORMANCE THIN LAYER CHROMATOGRAPHY; QUANTITATIVE ASSAY; TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 0032580909     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(98)00040-8     Document Type: Article

References (54)

1. [1] J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon (Eds.), Goodmann and Gilman's The Pharmacological Basis of Therapeutics, 9th ed., McGraw-Hill, New York, 1996, p. 250.
2. [2] M.W. de Vries, F.P. Peeters, Melatonin as a therapeutic agent in the treatment of sleep disturbance in depression, J. Nerv. Ment. Dis. 185 (1997) 201-202.
3. [3] J.E. Jan, M.E. O'Donnell, Use of melatonin in the treatment of paediatric sleep disorders, J. Pineal Res. 21 (1996) 193-199.
4. [4] A. Etzioni, R. Luboshitzky, D. Tiosano, M. Ben-Harush, D. Goldsher, P. Lavie, Melatonin replacement corrects sleep disturbances in a child with pineal tumor, Neurology 46 (1996) 261-263.
5. [5] D. Garfinkel, M. Laudon, D. Nof, N. Zisapel, Improvement of sleep quality in elderly people by controlled release melatonin, Lancet 346 (1995) 541-544.
6. [6] J.E. Jan, H. Espzel, R.E. Appleton, The treatment of sleep disorders with melatonin, Dev. Med. Child Neurol. 36 (1994) 97-107.
7. [7] C.P. Maurizi, The mystery of Alzheimer's disease and its prevention by melatonin, Med. Hypotheses 45 (1995) 339-340.
8. [8] W. Pierpaoli, A. Dall'Ara, E. Pedrinis, W. Regelson, The pineal control of aging. The effects of melatonin and pineal grafting on the survival of older mice, Ann. NY Acad. Sci. 621 (1991) 291-313.
9. [9] R. Sandyk, Melatonin supplements for aging, Int. J. Neurosci. 87 (1996) 219-224.
10. [10] T.Y. Chan, P.L. Tang, Effect of melatonin on the maintenance of cholesterol homeostasis in the rat, Endocrin. Res. 21 (1995) 681-696.
11. [11] R. Sandyk, G.I. Awerbuch, The relationship between melatonin secretion and serum cholesterol in patients with multiple sclerosis, Int. J. Neurosci. 76 (1994) 81-86.
12. [12] K. Petrie, A.G. Dawson, L. Thompson, R. Brook, A double blind trial of melatonin as a treatment for jet-lag in international cabin crew, Biol. Psychiatr. 33 (1993) 526-530.
13. [13] J. Arendt, M. Aldhous, V. Marks, Alleviation of jet-lag by melatonin: preliminary results of controlled double blind trial, Br. Med. J. (Clin. Res. Ed.) 292 (1986) 1170.
14. [14] K. Petrie, J.V. Conaglen, L. Thompson, K. Chamberlain, Effect of melatonin on jet-lag after long haul flights, Br. Med. J. 298 (1989) 705-707.
15. [15] Q.R. Regestein, M. Pavlova, Treatment of delayed sleep phase syndrome, Gen. Hosp. Psychiatr. 17 (1995) 335-345.
16. [16] A. Oldani, L. Ferini-Strambi, M. Zucconi, B. Stankov, F. Fraschini, S. Smirne, Melatonin and delayed sleep phase syndrome: ambulatory polygraphic evaluation, Neuroreport 6 (1994) 132-134.
17. [17] M. Dahlitz, B. Alvarez, J. Vignau, J. English, J. Arendt, J.D. Parkes, Delayed sleep phase syndrome response to melatonin. Lancet 337 (1991) 1121-1124.
18. [18] P.C. Konturek, S.J. Konturek, J. Majka, M. Zembala, E.G. Hahn, Melatonin affords protection against gastric lesions induced by ischemia-reperfusion possibly due to its antioxidant and mucosal microcirculatory effects, Eur. J. Pharmacol. 322 (1997) 73-77.
19. [19] D. Melchiorri, R.J. Reiter, A.M. Attia, M. Hara, M. Burgos, G. Nistico, Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats, Life Sci. 56 (1995) 83-89.
20. [20] List of Orphan Designation and Approvals, Office of Orphan Products Development, Food and Drug Administration, Rockville, MD, Last rev. 1998.
21. [21] P. Lissoni, S. Meregalli, L. Nosetto, S. Barni, G. Tancini, V. Fossati, G. Maestroni, Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone, Oncology 53 (1996) 43-46.
22. [22] P. Lissoni, S. Barni, F. Brivio, F. Rossini, L. Fumagalli, A. Ardizzoia, G. Tancini, A biological study on the efficacy of low-dose subcutaneous interleukin-2 plus melatonin in the treatment of cancer-related thrombocytopenia, Oncology 52 (1995) 360-362.
23. [23] S. Barni, P. Lissoni, M. Cazzaniga, A. Ardizzoia, S. Meregalli, V. Fossati, L. Fumagalli, F. Brivio, G. Tancini, A randomized study of low-dose subcutaneous interleukin-2 plus melatonin versus supportive care alone in metastatic colorectal cancer patients progressing under 5-fluorouracil and folates, Oncology 52 (1995) 243-245.
24. [24] R. Aldeghi, P. Lissoni, S. Barni, A. Ardizzoia, G. Tancini, A. Piperno, M. Pozzi, G. Ricci, A. Conti, G. Maestroni, Low-dose interleukin-2 subcutaneous immunotherapy in association with the pineal hormone melatonin as a first-line therapy in locally advanced or metastatic hepatocellular carcinoma, Eur. J. Cancer 30 (1994) 167-170.
25. [25] A. Lagana, A. Marino, G. Fago, B. Pardo-Martinez, M. Bizzarri, Sensitive assay for melatonin in human serum by liquid chromatography, Anal. Chim. Acta 316 (1995) 377-385.
26. [26] R. Dubbels, R. Reiter, E. Klenke, A. Goebel, E. Schnakenberg, C. Ehlers, H.W. Schiwara, W. Schloot, Melatonin in edible plants identified by radioimmunoassay and by high performance liquid chromatography-mass spectrometry, J. Pineal Res. 18 (1995) 28-31.
27. [27] M. Hariharan, S. Naickar, A.S. Hilibrand, Melatonin determination in urine by liquid chromatography using fluorometric detection, J. Liquid Chromatogr. Relat. Technol. 19 (1996) 1745-1756.
28. [28] J.F. Peniston-Bird, W.L. Di, C. Street, A. Kadva, M. Salteri, R.E. Silman, HPLC assay of melatonin in plasma with fluorescence detection, Clin. Chem. 39 (1993) 2242-2247.
29. [29] R. Vieira, J. Miguez, L. Maria, M. Aldegunde, Pineal and plasma melatonin as determined by high-performance liquid chromatography with electrochemical detection, Anal. Biochem. 205 (1992) 300-305.
30. [30] F. Raynaud, P. Pevet, Determination of 5-methoxyindoles in pineal gland and plasma samples by high performance liquid chromatography with electrochemical detection, J. Chromatogr. 564 (1991) 103-113.
31. [31] M.H. Mills, D.C. Finlay, P.R. Haddad, Determination of melatonin and monoamines in rat pineal using reversed phase ion-interaction chromatography with fluorescence detection, J. Chromatogr. 564 (1991) 93-102.
32. [32] V. Rizzo, D. Melzi, G. Achilli, G.P. Cellerino, Determination of neurochemicals in biological fluids by using an automated high performance liquid Chromatographic system with a coulometric array detector, J. Chromatogr. 536 (1991) 229-236.
33. [33] T. Azekawa, A. Sano, K. Aoi, H. Sei, Y. Morita, Concurrent on-line sampling of melatonin in pineal microdialysates from conscious rat and its analysis by high-performance liquid chromatography with electrochemical detection, J. Chromatogr. 530 (1990) 47-55.
34. [34] J.R.L. Chin, Determination of six indolic compounds, including melatonin, in rat pineal using high-performance liquid chromatography with serial fluorometric-electrochemical detection, J. Chromatogr. 528 (1990) 111-121.
35. [35] M.T. Itoh, A. Hattori, Y. Sumi, Hydroxyindole-o-methyltransferase activity assay using high-performance liquid chromatography with fluorometric detection: determination of melatonin enzymatically formed from N-acetylserotonin and S-adenosyl-L-methionine, J. Chromatogr. B: Biomed. Appl. 692 (1997) 217-221.
36. [36] A. Vitale, C. Ferrari, H. Aldana, J.M. Affanni, Highly sensitive method for the determination of melatonin by normal-phase high-performance liquid chromatography with fluorometric detection, J. Chromatogr. B: Biomed. Appl. 681 (1996) 381-384.
37. [37] T. Harumi, H. Akutsu, S. Matsushima, Simultaneous determination of serotonin, N-acetylserotonin and melatonin in the pineal gland of the juvenile golden hamster by high-performance liquid chromatography with electrochemical detection, J. Chromatogr. B: Biomed. Appl. 675 (1996) 152-156.
38. [38] A. Cavallo, M. Hassan, Stability of melatonin in aqueous solution, J. Pineal Res. 18 (1995) 90-92.
39. [39] S. Chegini, B. Ehrhart-Hofmann, A. Kaider, F. Waldhauser, Direct enzyme-linked immunosorbent assay and a radioimmunoassay for melatonin compared, Clin. Chem. 41 (1995) 381-386.
40. [40] D.K. Lahiri, D. Davis, J.I. Nurnberger Jr., Melatonin-like immunoreactivity in the presence of different chemicals as determined by the radioimmunoassay, Biochem. Med. Metab. Biol. 51 (1994) 51-54.
41. [41] G.M. Vaughan, New sensitive serum melatonin radioimmunoassay employing the Kennaway G280 antibody: Syrian hamster morning adrenergic response, J. Pineal Res. 15 (1993) 88-103.
42. [42] S.M. Yie, E. Johansson, G.M. Brown, Competitive solid-phase enzyme immunoassay for melatonin in human and rat serum and rat pineal gland, Clin. Chem. 39 (1993) 2322-2325.
43. [43] D.K. Lahiri, D. Davis, M. Adkins, J.I. Nurnberger Jr., Factors that influence radioimmunoassay of human plasma melatonin: a modified column procedure to eliminate interference, Biochem. Med. Metab. Biol. 49 (1993) 36-50.
44. [44] F.C. Leung, Circadian rhythms of melatonin release from chicken pineal in vitro: modified melatonin radioimmunoassay, Proc. Soc. Exp. Biol. Med. 198 (1991) 826-832.
45. [45] C. Tenn, L. Niles, A novel and sensitive radioreceptor assay for serum melatonin levels, Life Sci. 49 (1991) 1895-1900.
46. [46] B. Manz, A. Seidel, H. Alexander, L. Vollharth, B. Wagner, G. Zimmermann, K. Wiedemann, K. Pollow, Development and validation of a radioimmunoassay for serum melatonin, J. Clin. Chem. Clin. Biochem. 27 (1989) 797-802.
47. [47] B. Poeggeler, R. Hardeland, Detection and quantification of melatonin in a dinoflagellate, Gonyaulax polyedra: solutions to the problem of methoxyindole destruction in non-vertebrate material, J. Pineal Res. 17 (1994) 1-10.
48. [48] R. Dubbels, E. Klenke, B. Manz, J. Terwey, W. Schloot, Melatonin determination with a newly developed ELISA system. Interindividual differences in the response of the human pineal gland to magnetic fields, Adv. Pineal Res. 7 (1994) 27-33.
49. [49] J.B. Fourtillan, P. Gobin, B. Faye, J. Girault, A highly sensitive assay of melatonin at the femtogram level in human plasma by gas chromatography/negative ionization mass spectrometry, Biol. Mass Spectrom. 23 (1994) 499-509.
50. [50] C.R. Lee, H. Esnaud, Determination of melatonin by GC-MS: problems with solid phase extraction (SPE) columns, Biomed. Environ. Mass Spectrom. 15 (1988) 677-679.
51. [51] R.M. Leone, R.E. Silan, R.J.L. Hooper, M.D.A. Finnie, I. Smith, P. Francis, P.E. Mullen, C. Linsell, M. Savage, M. Preece, Gas chromatography-mass spectrometry assay for the measurement of melatonin and methoxytryptophol in plasma, J. Endocrinol. 83 (1979) 47-48.
52. [52] F. Crespi, E. Ratti, D.G. Trist, Melatonin, a hormone monitorable in vivo by voltammetry?. Analyst 119 (1994) 2193-2197.
53. [53] P. Baumann, Indoles (densitometry), in: J.C. Touchstone, J. Sherma (Eds.), Densitometry Thin Layer Chromatography, Wiley, New York, 1979, pp. 329-350.
54. [54] J.M. Arquè, J. Serrano, A. De Leiva, R. Segura, Separation and o-phthalaldehyde fluorometric determination of 5-hydroxy-and 5-methoxyindoleamines by thin-layer chromatography: selected applications, Anal. Biochem. 174 (1988) 275-279.